相关实验视频

Updated: Jun 12, 2025

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

评估莱维蒂拉塞坦的基于体重的剂量在性症患者的代谢耐药状态下

Nasma Torfah^1,2, Anthony Lau^2,3, Hans Haag^2,4

¹Surrey Memorial Hospital, Surrey, Canada.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

|March 27, 2025

概括

基于体重的Levétiracetam (LEV) 较高的负载剂量 (≥30 mg/kg) 在治疗抗zepine状态 (BRSE) 方面比较低的剂量 (<30 mg/kg) 更有效. 这一策略还降低了输管,ICU入院和死亡率.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.
关键护理医学关键护理医学

背景情况:

列维 (LEV) 是一种关键的抗发作药物 (ASM) 治疗状态.
临床实践因缺乏对LEV负载剂量进行对比而有所不同.
对于抗二胺耐药性状态 (BRSE) 的最佳LEV剂量存在不确定性.

研究的目的:

为了比较低 (<30毫克/公斤) 与高 (≥30毫克/公斤) 的基于体重的LEV负荷剂量的有效性和安全性.
为了评估LEV在终止BRSE的有效性.
评估二次结果,包括输管,ICU入院,死亡率和不良事件.

主要方法:

追溯性队列研究,对106名成年患者进行.
基于体重的低 (<30毫克/公斤) 与高 (≥30毫克/公斤) 的LEV负荷剂量的比较.
主要结局:发作终止 (定义为不需要额外的ASM).
二次结局:内管道输入,ICU入院,30天死亡率和不良药物反应.
统计分析包括后勤回归和胜利比率分析.

主要成果:

在51%的患者 (54/106) 中,发作终止.
较高的LEV剂量组显示出明显更高的止率 (66%对40%;aOR3.07).
高剂量组的内管道输入率,ICU入院率和全因死亡率较低.
两组之间的不良事件率是可比的.

结论:

基于体重的高负载剂量 (≥30 mg/kg) 的莱维他对于终止BRSE.更有效.
这种高剂量策略与改善的临床结果有关.
这些发现支持使用更高的LEV负载剂量用于BRSE治疗.

关键词:

抗发作药可以治疗发作.这是一种抗的抗药.莱维泰拉塞坦 ( levetiracetam) 的使用情况耐火材料耐火材料耐火材料发作发作发作

更多相关视频

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Arteries of the Lower Limbs

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

CNS Depressants: Barbiturates and Benzodiazepines

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...